• Explore /
  • Poster
  • / Double-loaded mature dendritic cell (DC) therapy for non-HLA-restricted patients with advanced ovarian cancer: Final results of a clinical phase I study.

Double-loaded mature dendritic cell (DC) therapy for non-HLA-restricted patients with advanced ovarian cancer: Final results of a clinical phase I study.

Abstract Poster

Authors

null

Marianne Imhof

Life Research Technologies, Wien, Austria

Marianne Imhof , Markus Lipovac , Lukas Angleitner-Boubenizek , Johannes Barta , Ivan Gomez , Astrid Hrdina , Ewa Krupa , Judith Lafleur , Istvan Lang , Katharin Pieta , Heike Rottmann , Martin Imhof

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT01456065

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3052)

DOI

10.1200/jco.2013.31.15_suppl.3052

Abstract #

3052

Poster Bd #

15C

Abstract Disclosures

Similar Posters

First Author: Bradley Corr

First Author: Timothy Jay Price

First Author: Robert O. Dillman

First Author: Masafumi Ikeda